Max Stabl
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 5%
- Electroconvulsive Therapy Studies
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
Papers in
- Pharmacology 19
- Treatment of Major Depression 18
-
- Electroconvulsive Therapy Studies 11
- Bipolar Disorder and Treatment 5
- Attention Deficit Hyperactivity Disorder 5
- Co-authors
- Jules Angst (5 shared papers)R. Amrein (9 shared papers)W. Schmid‐Burgk (5 shared papers)Márcio Versiani (2 shared papers)Kathleen Bizière (2 shared papers)Roman Fischbach (1 shared paper)Jasper Dingemanse (2 shared papers)Ulf Baumhackl (2 shared papers)
- Journals
- Psychopharmacology (3 papers)International Clinical Psychopharmacology (3 papers)Journal of Clinical Psychopharmacology (2 papers)Acta Psychiatrica Scandinavica (2 papers)The British Journal of Psychiatry (2 papers)
- Partner nations
- SwitzerlandAustriaBrazil
In The Last Decade
Max Stabl
23 papers receiving 644 citations
Peers
Comparison fields: 5 of 67
- Biological Psychiatry 72
- Psychiatry and Mental health 387
- Pharmacology 409
- Experimental and Cognitive Psychology 132
- Cellular and Molecular Neuroscience 109
Countries citing papers authored by Max Stabl
This map shows the geographic impact of Max Stabl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Stabl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Stabl more than expected).
Fields of papers citing papers by Max Stabl
This network shows the impact of papers produced by Max Stabl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Stabl. The network helps show where Max Stabl may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Stabl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 83 | |
| 2 | 1992 | 82 | |
| 3 | 1994 | 49 | |
| 4 | 1992 | 48 | |
| 5 | 1995 | 48 | |
| 6 | 1995 | 46 | |
| 7 | 1996 | 46 | |
| 8 | 1990 | 45 | |
| 9 | 1997 | 42 | |
| 10 | 1993 | 37 | |
| 11 | Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states. | 1989 | 33 |
| 12 | Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale. | 1993 | 29 |
| 13 | 1993 | 28 | |
| 14 | 1994 | 21 | |
| 15 | 1997 | 20 | |
| 16 | Antidepressant drug therapy: associated risks. | 1988 | 18 |
| 17 | 1995 | 14 | |
| 18 | 1996 | 14 | |
| 19 | 1995 | 13 | |
| 20 | 1993 | 11 |
About Max Stabl
Max Stabl is a scholar working on Pharmacology, Psychiatry and Mental health, Biological Psychiatry, Experimental and Cognitive Psychology and Clinical Psychology, having authored 23 papers that have together received 742 indexed citations. Recurring topics across this work include Treatment of Major Depression (18 papers), Electroconvulsive Therapy Studies (11 papers), Bipolar Disorder and Treatment (5 papers), Attention Deficit Hyperactivity Disorder (5 papers), Tryptophan and brain disorders (3 papers), Mental Health Research Topics (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Child and Adolescent Psychosocial and Emotional Development (1 paper). The work is most often cited by research in Biological Psychiatry (72 citations), Psychiatry and Mental health (387 citations), Pharmacology (409 citations), Experimental and Cognitive Psychology (132 citations) and Cellular and Molecular Neuroscience (109 citations). Max Stabl has collaborated with scholars based in Switzerland, Austria and Brazil. Frequent co-authors include Jules Angst, R. Amrein, W. Schmid‐Burgk, Márcio Versiani, Kathleen Bizière, Roman Fischbach, Jasper Dingemanse, Ulf Baumhackl, G. F. Hebenstreit and Antônio Egídio Nardi. Their work appears in journals such as Psychopharmacology, International Clinical Psychopharmacology, Journal of Clinical Psychopharmacology, Acta Psychiatrica Scandinavica and The British Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.